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Abstract
Background: Q fever, caused by Coxiella burnetii, is a zoonosis that presents a worldwide distribution and affects
both humans and animals. The route of dispersal of the pathogen by ruminants into the environment usually
involves stages of abortion and parturition, nevertheless the agent can, also, be detected in other animal
samples. Therefore it is considered as important in terms of proper diagnosis, as well as, for epidemiology
and surveillance purposes, to genotype the pathogen. The aim of the current study was to investigate the
presence of different genotypes of the agent in animals that had suffered from abortion during a two-year
survey in Greece.
Results: Sixty nine tissue samples (37 stomach contents, 11 liver samples, 21 cotyledons) were collected from
59 abortion cases in sheep (N = 45) and goats (N = 14) from 65 farms at eight different areas of Greece. Samples were
screened by qPCR and positive ones were further genotyped using a 10-locus multiple loci (ms 1, 3, 7, 12, 20, 21, 22,
26, 30 and 36) variable number of tandem repeat analysis (MLVA) method.
Three genotypes were identified in sheep (A, B, C). Samples representing each of the obtained MLVA profile were
further used for MST genotyping. Ten spacers (Cox 2, 5, 6, 18, 20, 22, 37, 51, 56 and 57) were amplified. A close
relatedness among the identified MLVA genotypes was confirmed since they all belonged to MST group 32.
Conclusions: The current study introduces into the aspect of genotyping of C. burnetii in Greece. Further studies
are needed to explore the presence of more genotypes, to associate the genotypes circulating in the animal and
tick population with those causing human disease in order to further expand on the epidemiological aspects of
the pathogen.
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Background
Q fever, caused by the pathogen Coxiella burnetii, is a
zoonosis with a worldwide distribution [1]. The presence
of the pathogen has been reported in a great variety of
animals including wild and domestic mammals (goats,
sheep, cows, buffaloes and potentially other dairy rumi-
nants, more rarely dogs and cats). The agent has, also,
been detected in ticks, although there is still controversy
on whether these arthropods can act both as reservoirs
for maintaining C. burnetii in nature and as vectors for
transmitting it to humans.
Domestic ruminants (particularly sheep, goats, and
cattle) are often asymptomatic carriers of the pathogen
or express mild clinical manifestations associated with
abortion, stillbirth, placentitis, endometritis and infer-
tility [2–4]. These animals, either ill or healthy (car-
riers), are considered the major source of infection to
humans [1]. In fact, a vast number of bacteria can be
shed by domestic ruminants through milk, faeces, vagi-
nal secretions and mostly placenta and birth products.
Coxiella burnetii spores are highly infectious and stable
under environmental conditions and are easily dispersed
by airflow, that is why the main route of infection is
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considered to be inhalation of contaminated aerosols or
dust [5]. Spores can, also, be spread several kilometers
away from the primary infection source through wind,
raising the latter as a potential player for bacterial dis-
persal [6].
It is of great importance to be able to trace back the
sources of infection and to characterize the strains of the
pathogen present in certain areas, both for epidemio-
logical and for public health reasons (for example, sur-
veillance purposes and trace of Q fever outbreaks). The
most up to date event that leads towards the necessity of
tracing and surveying the source of infection was the
outbreak that took place in the Netherlands (2007–2010).
This event has drawn further attention on the study of the
pathogen even in countries where a low prevalence of the
disease was usually recorded, as was the case of the
Netherlands until the outbreak episodes [1, 7]. To achieve
such a demanding goal, the most reliable way is to use
molecular tools for the genotypic characterization of C.
burnetii in order to evaluate the epidemiological link be-
tween the source of the outbreak and human and/or ani-
mal cases. The ultimate goal in any case is to establish
control measures with respect to hosts involved in the life
cycle of the pathogen in order to minimize or even just
survey its dispersal.
A number of different molecular typing methods have
been used to achieve the above mentioned goals includ-
ing, restriction fragment length polymorphism (RFLP) in
combination with pulse field gel electrophoresis (PFGE)
[8, 9], multi-locus variable number of tandem repeats
analysis (MLVA; more than 20 publications following the
1st one in 2006 [10]), multispacer sequence typing (MST)
[11], and single nucleotide polymorphism (SNP) [12, 13].
Of the mentioned techniques, MLVA and MST have
proved to be reliable, reproducible, and present a high
discriminatory power. They do not require cultivation
of the pathogen, which not only is it difficult to achieve
but, also, obliges Biosafety Level (BSL) 3 facilities, while
there is always the possibility of isolation failure due to
contamination (especially in abortion samples). As far
as MLVA is concerned, it is now considered as the ref-
erence method for a number of other pathogens: Myco-
bacterium tuberculosis [14], Bacillus anthracis [15], and
Yersinia pestis [16]. MLVA is particularly useful in cases
where there is a need for a deeper study of new genome
sequences [17, 18].
In Greece, despite the fact that reporting of Q fever
should be mandatory, no more than 40 human cases are
recorded annually at the Hellenic Center for Disease and
Control, making its incidence possibly underestimated.
Moreover, the absence of C. burnetii routine testing of
animals of veterinary interest, leads to the conclusion
that very few animal cases are recorded on an annual
basis. A number of studies have been carried out in
Greece during the last 20 years in humans in order to
document the prevalence of the disease, its potential
complications, describe the difference in the kinetics of
the antibodies between acute and chronic Q fever, iden-
tify possible proteins of the pathogen involved in the dis-
ease and their potential virulence, etc.; nevertheless,
there is no information on the genotypic diversity of the
pathogen circulating in the country (at the discussion
section we comment further on the studies carried out
in the country so far).
In the current study, C. burnetii DNA obtained from
small ruminant abortion samples was genotyped. We
introduce the use of MLVA and of MST in the study of
the genetic diversity of the pathogen that is circulating
in the country, as a first step to establish the link with
potential sources of human infection.
Methods
Sampling
Samples were collected from 59 abortion episodes that
occurred in sheep (N = 45) and goats (N = 11) from De-
cember 2014 to November 2016. The study enrolled 65
farms situated in middle, north, northeastern and north-
western Greece (Fig. 1). A total of 69 samples consisting
of stomach content (N = 45), liver samples (N = 11) and
cotyledons (N = 14), were obtained collected immedi-
ately after the abortion, packaged with ice and trans-
ported to the Farm Animal Clinic for examination.
Molecular analysis
DNA extraction was performed at the Clinic of Farm Ani-
mals, Faculty of Veterinary Medicine, School of Health
Sciences, Aristotle University of Thessaloniki, using the
QIAamp Tissue kit (QIAGEN Gmbh, Hilden, Germany).
The concentration of extracted DNA was measured as the
optical density at 260 nm using the Nanodrop 2000 pho-
tometer (Thermo Scientific). DNA samples were stored at
-20 °C until further analysis. The initial qPCR screening of
the samples and the MLVA genotyping were performed
at the unit of Zoonoses of the Department of Clinical
Microbiology and Microbial Pathogenesis (National
Reference center for tick-borne pathogens), School of
Medicine, University of Crete. The MST genotyping
was carried out at the Center for Vectors and Infectious
Disease Reserach, National Institute of Health Doutor
Ricardo Jorge, Portugal.
Real-time polymerase chain reaction (qPCR)
To screen for the presence of C. burnetii DNA a qPCR
was performed targeting the repeated sequence IS1111
[19]. The 20 μl reaction consisted of mastermix (Bio-
Rad), 0.4 μM of each primer, 0.2 μM of probe and 2.5 μl
of DNA sample. Amplification was carried out in a CFX96
C1000 Real-time PCR (BioRad), under the following
Chochlakis et al. BMC Microbiology          (2018) 18:204 Page 2 of 9
conditions: one cycle at 95 °C for 180 s, 40 cycles at 95 °C
for 10s and 55 °C for 30s. Results were generated with
CFX Manager Software v. 1.6 (BioRad). Samples showing
cycle threshold (Ct) values of 31 or lower for C. burnetii
IS1111 qPCR assays were considered positive, according
to an already described procedure [20]. DNA extracted
from a Nine Mile strain (RSA 493) strain, which is main-
tained in culture (Vero cells) at the laboratory, was used
as a positive control and double distilled water was used
as a negative one.
Multiple-locus variable-number tandem repeat analysis
(MLVA)
All C. burnetii positive samples were further used for
MLVA genotyping. Ten different loci (ms 1, 3, 7, 12, 20,
21, 22, 26, 30 and 36) were selected for DNA amplifica-
tion, as previously described [10, 21]. Nine Mile strain
(RSA 493) for which the expected MLVA pattern is
known, was used as a reference control strain to assist
with the interpretation and the estimation of the number
of repeat units. Following gel electrophoresis, the number
Fig. 1 Geographical distribution of the genotypes (A, B, C) detected in the animals (sheep) tested positive by qPCR
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of repeats in each marker was determined by extrapo-
lating the sizes of the reference strain from those ob-
tained from our samples. According to the established
consensus, the genotype of the Nine Mile strain is now
designated as 4–7–8-8-15-6-6-4-12-4 for markers ms01,
ms03, ms07, ms12, ms20, ms21, ms22, ms26, ms30 and
ms36, respectively. Differences in PCR products were ana-
lysed using the Alpha View software v. 3 (Alpha Innotech).
MLVA tools and databases of several organisms were
accessed over the website http://mlva.u-psud.fr/mlvav4/
genotyping/view.php. This database was made available in
2014 aggregating mainly data published in 2006 by
Arricau-Bouvery et al. (“C. burnetii 2007 Orsay” database),
data provided by Kinga Sulyok, Miklós Gyuranecz and
col., Institute for Veterinary Medical Research, Budapest,
Hungary (“C. burnetii 2014” Hungary database) and data
produced since 2007 by Jeroen Tilburg et al. (“C. burnetii
2014 Nijmegen” database).
Multi-spacer sequence typing (MST)
Samples representing each of the obtained MLVA profile
were used for MST genotyping. In order to achieve that,
ten different spacers (Cox 2, 5, 6, 18, 20, 22, 37, 51, 56
and 57) of the C. burnetii genome were amplified, as de-
scribed elsewhere [11, 22]. Conventional PCRs were per-
formed in 50-μl reaction using 1× FastStart Master Mix
(Roche Diagnostics), containing 0.5 μM of amplification
primers and 5 μl of DNA sample. After amplification
purification and sequencing, the forward and reverse se-
quences generated for each of the 10 loci were aligned
on the DNAStar sequence analysis software. The MST
group was then identified using a web-based MST data-
base (http://ifr48.timone.univ-mrs.fr/mst/coxiella_burne-
tii// mst/coxiella_burnetii/strains.html). In order to
integrate the C. burnetii DNA detected, a phylogenetic
analysis was performed using the MEGA v.7 software
[23] using concatenated sequences of most of the known
MST genotypes. The evolutionary distances were in-
ferred using the Neighbor-Joining method (computing
the Maximum Composite Likelihood method) and
expressed in the number of base substitutions per site
by pair wise comparison of 48 nucleotide sequences
(Fig. 2). The eco-epidemiological context of MST geno-
types, i.e. information on geographical distribution, oc-
currence and affected animal host, was compiled from
the open-source MST database and from several pub-
lished papers.
Results
Of the 69 samples tested, 11 (15.9%) were positive by
qPCR and were further genotyped by MLVA. All sam-
ples originated from sheep abortion cases that occurred
in 11 farms located in eight different regions (Table 1 and
Fig. 1). Attempts to genotype two samples with higher Cq
values were unsuccessful probably due to the lower C.
burnetii DNA content. Furthermore, we failed to amplify
locus ms26 despite repetitive attempts. Three different ge-
notypes were detected in 11 samples: “A” was the most
common and was detected in nine samples; “B” and “C”
were detected in one sample each. Genotype B differed at
the size of a single locus (ms22) only, compared to most
prevalent genotype A, by a number of 33 bp, while geno-
type C differed at the size of three loci (ms22, ms30 and
ms36) by a size of 66 bp, 18 bp and 45 bp respectively,
when compared to the most prevalence genotype A (Table
1). The dispersal of genotype A did not follow any particu-
lar pattern, since it was detected both in northern, central
and in southern areas of the country. These genotypes
represented unique MLVA profiles when compared to
those deposited in open-access banks (http://mlva.u-p-
sud.fr/MLVAnet/spip.php?rubrique50, http://microbe-
sgenotyping.i2bc.paris-saclay.fr/databases/).
To complement the molecular analysis and to try to
find a match with previous detected C. burnetii geno-
types, one sample representing each of the MLVA pro-
file was, also, used for MST typing. This is a less
discriminatory method however, it is broadly used and
has a standardized nomenclature allowing easy com-
parison of results among laboratories. The obtained re-
sults, confirmed the close relatedness among the MLVA
genotypes A, B, C since they were all identified as be-
longing to MST group 32. The allele codes found were
3–5–1-6-5-4-5-12-3-2 for spacers Cox2-Cox5-Cox18-
Cox20-Cox22-Cox37-Cox51-Cox56-Cox57-Cox61. This
MST genotype has been previously identified colonizing
human cardiac valves in France and Germany, goat pla-
centa in Austria (http://ifr48.timone.univ-mrs.fr/mst/cox-
iella_burnetii/strains.html) and sheep milk products in
Tuscany, Italy [24]. The Neighbor-joining tree demostrat-
ing the placement of MST 32 (including the C. burnetii
strain detected in this study) and the phylogenetic rela-
tionship with other genotypes, reinforce this zoonotic
role (Fig. 2). MST 32 is placed in a tree branch (bootstrap
of 70) that comprises several genotypes that particularly
affect humans (60 samples) and small domestic ruminants
(31 samples), and in a lesser extent cattle (4 samples) (Fig.
2 and Table 1). The data used to produce Fig. 2 are pre-
sented at Additional file 1: Table S1.
Discussion
In Greece, the notification of human Q fever cases is
mandatory however under-reporting is one of the main
limitations in disease assessment. There is, also, no con-
tinuous and reliable recording of the distribution of hu-
man and animal cases in the country thereafter, the
identification of the source and route of infection re-
mains largely unknown. More than 30 studies have been
carried out during the past 20 years in Greece in an
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attempt to expand the knowledge on C. burnetii; they
have been focused on the pathogen isolation from
humans [25] and the associated disease [26], its detec-
tion in ticks [27], on antibiotics resistance [28] and on
proteomic analysis [29–31]. Despite the above, very few
information is available regarding strain diversity. This
study increases knowledge on the subject with the
MLVA and MST-typing of nine C. burnetii positive sam-
ples obtained from different areas of Greece, deciphering
its potential zoonotic role.
Overall, three MLVA genotypes (A, B and C) were de-
tected in the current study. Genotype A was the most
Fig. 2 The placement of the C. burnetii strain detected in this study (represented by sample 173, highlighted in grey) with the known
MST genotypes. The analysis was performed using MEGA v.7 software (Kumar et al., 2016 [23]) using the Neighbor-joining method (Maximum Composite
Likelihood method) with 1000 replicates. Bootstrap values > 50 are shown. The scale bar represents the number of nucleotide substitutions
per site. Host and geographic origin of C. burnetii genotypes are provided, according to open source databases and previous publications
(listed in Additional file 1: Table S1). Country codes used: CE-Republic of Crimea; CF-Central African Republic; CH-Switzerland; CZ-Czech
Republic; D-Germany; E-Spain; ET-Ethiopia; F-France; GF-French Guiana; GR-Greece; H-Hungary; I-Italy; JP-Japan; KZ-Kazakhstan; MN-Mongolia; NL-
Netherlands; NM-Namibia; P-Portugal; PL-Poland; RO-Romania; RU-Russia; S-Sweden; SA-Saudi Arabia; SE-Senegal; SK-Slovakia; TN- Tunisia; UK-United
kingdom; UKR-Ukraine; US-United States; UZB-Uzbekistan. 1Reference strains: MSU Goat Q177 (Genbank accession number CP18150); Cbuk_Q154
(access no CP001020); Heizberg (access no CP014561); 14,160–002 str (access no CP014836); Namibia str (access no CP007555); Dugway (access no
CP000733); CbuG_Q212 (access no CP001019); Scurry_Q217 (access no CP014565); Henzerling (RSA 331) (access no CP000890); Nine Mile (RSA 493)
(access no AE016828.);Cb175-Guyana (access no HG825990); Z3055 (access no LK937696); RT-Schperling (access no CP014563)
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dominant occurring in different areas of the country,
some separated by hundreds of kilometers. This large
distribution may be due to the movement of animals
from one place to another, or to a common animal sup-
plier (who does not necessarily have to be Greek). Since
only sheep samples have been genotyped, it can also be
claimed that C. burnetii strains circulating in this animal
population in Greece are very similar and more/other
MLVA loci may be need to increase the discriminatory
power. For example, we have failed to amplify the locus
ms26 independently from the specimen and the qPCR
Ct values; the reason for this depletion has already been
explained in a recent study [32] according to which, the
loss of ms26 is due to a deletion occurring between
CBU_0877 and CBU_0881.
The genotypes identified in the current studied were
designated as novel ones since no correspondence was
found among the loci repeats profiles detected herein
and those identified in other European studies, which
have been deposited at the open web-site http://
mlva.u-psud.fr/MLVAnet/spip.php?rubrique50. Inter-
estingly, the representatives of each of these three
MLVA genotypes were found to be identical based on
the 10- spacers MST panel and were identified as be-
longing to MST 32 group when the spacer’s profile
was compared with those deposited at http://ifr48.ti-
mone.univ-mrs.fr/mst/coxiella_burnetii/strains.html.
Up to now the information regarding C. burnetii di-
versity in Greece was restricted to the description of
Heizenberg str from an human sample, a strain close
related to MST 18 [11]. This study increased the num-
ber of C. burnetii strains with zoonotic potential
which are associated to small ruminants and circulate
in the Hellenic territory. MST 32 was previously re-
corded in human specimens, heart valve (Germany)
and aortic biopsy (France), in a goat placenta (Austria)
and sheep soft cheese (Italy) [11, 24].
The increased use of molecular methods for epidemio-
logical purposes has proven to be of great value both in
the identification of animals seeding C. burnetii and
tracking-back the disease, especially when accompanied
by typing schemes. Since the first proposition of a panel
to be used for the genotyping of C. burnetii [10, 11], a
number of studies have been carried out throughout
Europe to increase knowledge on the circulating strains.
Effort has been made to genotype as many positive sam-
ples as possible and to expand the panel used, introdu-
cing more loci to increase strain identification. The main
focus has been put into MLVA and MST. In fact is has
been suggested that MLVA presents the highest dis-
criminatory power [33], while different techniques seem
to agree among each other [34, 35]. The great advan-
tage of both methods (but of MLVA in particular) is
that they do not require the isolation of the pathogen
[10, 11]. Genomic analyses can be made using directly
the DNA purified from most type of samples, although
results are best achieved if high bacterial load is
present, as in the case of aborted material. Further-
more, typing by MLVA can be easily standardized since
it has become pretty much straightforward and can be
performed without the need of a large budget, and may
prove of great usefulness in case of large-scale molecu-
lar epidemiology investigations [10]. It has, also, been
shown that the selected MLVA markers are of high
quality and show considerable stability [36], which is of
particulate importance since regions that evolve too
Table 1 Amplification of 10 loci from panel A as this has been established (http://mlva.u-psud.fr//MLVAnet/spip.php?rubrique50)
ID Host Source Location Year Ct MLVA MST
typeLoci targeted Type
ms01 ms03 ms07 ms12 ms20 ms21 ms22 ms26 ms30 ms36
27 Sheep Stomach content Grevena 2015 27.1 0 0 0 -2 3 0 −7 N/A 0 3 A
45/2 Sheep Stomach content Elassona 2015 28.6 0 0 0 −2 3 0 −7 N/A 0 3 A
85/1 Sheep Cotyledon Kalavryta 2014 29.9 0 0 0 −2 3 0 −7 N/A 0 3 A
85/1 Sheep Stomach content Kalavryta 2014 27.4 0 0 0 −2 3 0 −7 N/A 0 3 A
92 Sheep Liver Edessa 2015 28.3 0 0 0 −2 3 0 −7 N/A 0 3 A
113 Sheep Stomach content Thessalonika 2015 23.5 0 0 0 −2 3 0 −4 N/A 0 3 B 32
152/2 Sheep Cotyledon Patra 2016 29.1 0 0 0 −2 3 0 −7 N/A 0 3 A
156/B Sheep Stomach content Aridea 2016 28.4 0 0 0 −2 3 0 −7 N/A 0 3 A
173 Sheep Liver Elassona 2016 24.6 0 0 0 −2 3 0 −7 N/A 0 3 A 32
173 Sheep Stomach content Elassona 2016 23.7 0 0 0 −2 3 0 −7 N/A 0 3 A 32
14/1 Sheep Cotyledon Larissa 2017 24.2 0 0 0 −2 3 0 1 N/A −1 9 C 32
ID Sample Identification number, Ct Real-time PCR cycle threshold, N/A not determined DNA. The genotypic designation of Nine Mile (4–7–8-8-15-6-6-4-12-4, for
the corresponding loci) was used to compare our findings. Where “0”, we ended up with the same band size during the MLVA typing; differences either these are
“-” or “+” correspond to differences in number of repeats among our samples and Nine Mile. MLVA and MST genotypes were confirmed in C. burnetii 2014
cooperative database (http://mlva.u-psud.fr/mlvav4/genotyping/view.php) (http://ifr48.timone.univ-mrs.fr/mst/coxiella_burnetii/strains.html)
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rapidly may prove misleading during an epidemiological
surveillance [37].
A point of concern regarding MLVA is the presence of
PCR products of unexpected size and/or failures to amp-
lify certain loci, an aspect for which little has been dis-
cussed. For instance, a study carried out recently has
shown that locus ms36 contains the full sequence of
locus ms20. Thus, it may be possible that primers target-
ing ms36 may well amplify both loci resulting in a PCR
product whose size may depend on the variations at the
9 bp motif of ms36, the 18 bp motif of ms20 or at both
[32]. Further attention is required when analyzing the
results to avoid mis-calculations that may lead to erro-
neous comparisons with data of other studies [38, 39]. A
step forward on this has been made through the recent
introduction of the microfluidics technology on the field
of MLVA typing. A recent study [40] showed that this
technology proved to be more reliable and more sensi-
tive when compared to standard electrophoretic tech-
niques, which could add reproducibility, sensitivity and
high fidelity to the procedure of typing, making the qual-
ity of the results produced being comparable to those of
sequencing. Moreover, the lack of harmonization of
the MLVA panels and of the loci amplified, allied with
the high discriminatory power is leading to results that
are difficult to compare among each other [21, 41],
which in turn makes sometimes inter-laboratory com-
parison of results difficult. Thus, it is advantageous to
associate MLVA with another typing method, such as
MST [36]. As shown here, the selection of this latter
method that is less discriminatory and uses standard-
ized nomenclature enables the integration of the re-
sults obtained in this study. Adding to the above the
use of plasmid characterization in addition to MLVA
and MST typing has, also, been proposed [35]. Such
an approach may help towards the better deepening
on the elucidation of the source of some of the already
described genotypes.
In any case, human isolates need to be tested [an at-
tempt towards this direction has already been made by a
research group in Hungary [42] using similar techniques
in an attempt to identify the genotypes causing disease
in humans, their virulence, the different symptoms or
their duration that may cause, etc. At the same time, a
number of issues need to be resolved when working with
human samples, since the human blood may contain
much lower DNA concentration compared to animal
samples (abortion materials, swabs, etc). In fact, in a
study carried out in Croatia [38] the authors failed to
amplify by MLVA any of the samples that came out posi-
tive by conventional PCR and they attributed this finding
to low DNA concentration [7].
To establish the link between the source of C. burne-
tii and a disease case or an outbreak it is crucial to
obtain the proper sample. Under this context, abortion
material may prove valuable providing information on
the genotypic diversity but it constitutes only one ap-
proach to tracking-back the C. burnetii source. Envir-
onmental samples such as surface swabs and aerosols
may, also, prove of particular interest [43]. In fact, con-
taminated aerosols are considered as one of the most
important transmission routes for C. burnetii, especially
when the environmental conditions favor dispersal by
aerosol means [6, 44]. Actually, it has been proven that
large quantities (> 3 × 107 GE per gram of feces or 103
GE per swab) of the pathogen may remain in faeces
and vaginal mucus for more than 2 months [45]. Fe-
male ruminants that may suffer from abotrions, also
called “superspreaders” [46], release large bacterial bur-
dens into the environment; this aspect together with
the viability of the pathogen in litter and manure in-
fected by birth products, makes the need for testing
other materials as well, more than necessary. It has,
also, been suggested that typing of C. burnetii geno-
types associated with the wildlife may prove of great
importance towards the identification of a potential
epidemiological link between wildlife and human and/
or livestock cases [47].
In Greece there are no past data because of the ab-
sence of any isolates from ruminants over the past de-
cades. Therefore, the current survey constitutes the
first attempt to genotype C. burnetii strains in Greece.
Certainly much more work needs to be done and many
more samples need to be tested in order to record as
many different genotypes as possible, as well as, to
cover most of the country territory. Furthermore, there
is certainly a need to compare strains from abortion
animals against those of healthy ones. The collection
of such data and their comparison with data deposited
in international databases will help towards both the
continuing of the active surveillance and strain geno-
typing of the pathogen, as well as, to the better under-
standing of the epidemiology of the disease across
Europe.
Conclusion
Genotyping of C. burnetii in a region is critical when
trying to identify the major sources of infection, and to
implement efficient farm-based control measures. MLVA
analysis has been proven as a great molecular tool, the
great advantage of which is that it does not require the
isolation of the pathogen.
This is the first report of genotypic diversity among C.
burnetii strains from Greece. Despite the low number of
positive samples tested in our study, we have tried to
make the first step on the introduction of genotyping of
C. burnetii in the country. Certainly, there is much more
Chochlakis et al. BMC Microbiology          (2018) 18:204 Page 7 of 9
to do in terms of animal surveillance and of human iso-
lates that need to be genotyped, as well.
Additional file
Additional file 1: Table S1. List of data from studies that have been
already carried out in Europe on the aspect C. burnetii genotyping.
These data were used to build Fig. 2. The corresponding references
of the studies are also provided at a separate tab into the file. (XLSX 50 kb)
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